Hepatitis B virus-related intrahepatic cholangiocarcinoma originates from hepatocytes

Zimin Song(Sun Yat-sen University), Shunli Shen(Sun Yat-sen University)

Hepatology International

June 27, 2023

10.1007/s12072-023-10556-3

Cited by 20

Related Papers

Targeting tumour-intrinsic N <sup>7</sup> -methylguanosine tRNA modification inhibits MDSC recruitment and improves anti-PD-1 efficacy

|Gut|2022|79

Combination Neoantigen-Based Dendritic Cell Vaccination and Adoptive T-Cell Transfer Induces Antitumor Responses Against Recurrence of Hepatocellular Carcinoma

|Cancer Immunology Research|2022|72

Distinct single-cell immune ecosystems distinguish true and de novo HBV-related hepatocellular carcinoma recurrences

|Gut|2023|66

Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial

|The Lancet. Gastroenterology & hepatology|2025|39